Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Normalization after clofibrate treatment.
- 1 May 1993
- journal article
- abstracts
- Published by Wolters Kluwer Health in Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Vol. 13 (5) , 712-719
- https://doi.org/10.1161/01.atv.13.5.712
Abstract
The influence of different plasma triglyceride concentrations on the heterogeneity of low density lipoprotein (LDL) and on the susceptibility of LDL to copper oxidation was investigated. By density gradient ultracentrifugation, LDL subfractions were isolated from the plasma of 10 normolipidemic control subjects and 12 hypertriglyceridemic patients both before and after clofibrate treatment. In the plasma of control subjects three LDL subfractions were present: LDL1 (d = 1.030-1.033 g/mL), LDL2 (d = 1.033-1.040 g/mL), and LDL3 (d = 1.040-1.045 g/mL). In the plasma of nine moderately hypertriglyceridemic subjects up to five LDL subfractions could be detected: LDL1-LDL3, LDL4 (d = 1.045-1.049 g/mL), and LDL5 (d = 1.049-1.054 g/mL). This polydispersity of LDL was replaced by monodispersity with increasing plasma triglyceride concentrations in three subjects with chylomicronemia, in whom LDL was concentrated in the narrow LDL5 density range. Clofibrate treatment resulted in a lighter LDL subfraction pattern (LDL1-LDL4). In both the control and the moderately hypertriglyceridemic subjects, the small dense LDL subfractions appeared more prone to oxidative modification in vitro than the light LDL subfractions, as measured by the decreased lag time preceding the onset of lipid peroxidation. Furthermore, the dense LDL subfractions were more extensively modified over time, as shown by an increased oxidation rate and a greater number of dienes formed after 6 hours of oxidation. These results suggest an enhanced atherogenic potential of the small, dense LDL subfractions within each LDL subfraction profile. The hypertriglyceridemic LDL subfractions before therapy (LDL3-LDL5) were less resistant to in vitro oxidation than the light, control LDL subfractions (LDL1-LDL3).(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 30 references indexed in Scilit:
- Low-density lipoprotein subclasses and risk of coronary artery diseaseCurrent Opinion in Lipidology, 1991
- Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoproteinAtherosclerosis, 1990
- Interruption of long-term lipid-lowering treatment with bezafibrate in hypertriglyceridaemic patients Effects on lipoprotein composition, lipase activities and the plasma lipid fatty acid spectrumAtherosclerosis, 1990
- The Role of Vitamin E and Carotenoids in Preventing Oxidation of Low Density LipoproteinsaAnnals of the New York Academy of Sciences, 1989
- Beyond CholesterolNew England Journal of Medicine, 1989
- Abnormal regulation of LDL receptor activity and abnormal cellular metabolism of hypertriglyceridaemic low density lipoprotein: normalization with bezafibrate therapyEuropean Journal of Clinical Investigation, 1987
- The triglyceride issue: A view from FraminghamAmerican Heart Journal, 1986
- Defective metabolism of hypertriglyceridemic low density lipoprotein in cultured human skin fibroblasts. Normalization with bezafibrate therapy.Journal of Clinical Investigation, 1985
- Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid estersAtherosclerosis, 1980
- Changes in the fatty acid composition of the plasma lipid esters during lipid-lowering treatment with diet, clofibrate and niceritrol Reduction of the proportion of linoleate by clofibrate but not by niceritrolAtherosclerosis, 1980